These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 9397154
1. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. Gopalbhai K, Meloche S. J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154 [Abstract] [Full Text] [Related]
2. Delay in serum stimulation of Erk activity caused by oncogenic transformation. Greulich H, Reichman C, Hanafusa H. Oncogene; 1996 Apr 18; 12(8):1689-95. PubMed ID: 8622889 [Abstract] [Full Text] [Related]
3. Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts. Kortenjann M, Shaw PE. Oncogene; 1995 Nov 16; 11(10):2105-12. PubMed ID: 7478530 [Abstract] [Full Text] [Related]
4. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP. Pettiford SM, Herbst R. Oncogene; 2000 Feb 17; 19(7):858-69. PubMed ID: 10702794 [Abstract] [Full Text] [Related]
5. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases. Warnecke C, Kaup D, Marienfeld U, Poller W, Yankah C, Gräfe M, Fleck E, Regitz-Zagrosek V. J Mol Med (Berl); 2001 Sep 17; 79(9):510-21. PubMed ID: 11692164 [Abstract] [Full Text] [Related]
6. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Ward Y, Gupta S, Jensen P, Wartmann M, Davis RJ, Kelly K. Nature; 1994 Feb 17; 367(6464):651-4. PubMed ID: 8107850 [Abstract] [Full Text] [Related]
7. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN, Abramova MV, Svetlikova SB, Darieva ZA, Pospelova TV, Pospelov VA. Oncogene; 2002 Jan 24; 21(5):719-30. PubMed ID: 11850800 [Abstract] [Full Text] [Related]
8. Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. Mivechi NF, Giaccia AJ. Cancer Res; 1995 Dec 01; 55(23):5512-9. PubMed ID: 7585624 [Abstract] [Full Text] [Related]
9. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV. Hepatology; 1997 Dec 01; 26(6):1484-91. PubMed ID: 9397988 [Abstract] [Full Text] [Related]
10. [MAP-kinase cascade analysis in transformed cell with different abilities to make G1/S block under serum starvation]. Savel'eva IA, Bykova TV, Aksenov ND, Pospelov VA, Pospelova TV. Tsitologiia; 2003 Dec 01; 45(5):493-9. PubMed ID: 14521057 [Abstract] [Full Text] [Related]
11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD. Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018 [Abstract] [Full Text] [Related]
12. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Jain N, Zhang T, Fong SL, Lim CP, Cao X. Oncogene; 1998 Dec 17; 17(24):3157-67. PubMed ID: 9872331 [Abstract] [Full Text] [Related]
13. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling. Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM. J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703 [Abstract] [Full Text] [Related]
14. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA, Baumann H. Hepatology; 1999 Sep 15; 30(3):682-97. PubMed ID: 10462375 [Abstract] [Full Text] [Related]
15. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J. J Immunol; 1999 Jul 15; 163(2):802-10. PubMed ID: 10395673 [Abstract] [Full Text] [Related]
16. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H. Oncogene; 1997 May 22; 14(20):2435-44. PubMed ID: 9188858 [Abstract] [Full Text] [Related]
17. A role for Ras in v-Crk transformation. Greulich H, Hanafusa H. Cell Growth Differ; 1996 Nov 22; 7(11):1443-51. PubMed ID: 8930393 [Abstract] [Full Text] [Related]
18. Differential regulation of extracellular signal-regulated kinase 1 and 2 activity during 12-O-tetradecanoylphorbol 13-acetate-induced differentiation of HL-60 cells. Meighan-Mantha RL, Wellstein A, Riegel AT. Exp Cell Res; 1997 Aug 01; 234(2):321-8. PubMed ID: 9260900 [Abstract] [Full Text] [Related]
19. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ, Marx M, Calothy G, Blair DG. Cell Growth Differ; 1995 Jan 01; 6(1):27-38. PubMed ID: 7718484 [Abstract] [Full Text] [Related]
20. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. Yamada M, Komatsu N, Okada K, Kato T, Miyazaki H, Miura Y. Biochem Biophys Res Commun; 1995 Dec 05; 217(1):230-7. PubMed ID: 8526916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]